4.52|3.38|6.93
委比:--
委差:--
卖五 | -- | -- |
卖四 | -- | -- |
卖三 | -- | -- |
卖二 | -- | -- |
卖一 | -- | -- |
买一 | -- | -- |
买二 | -- | -- |
买三 | -- | -- |
买四 | -- | -- |
买五 | -- | -- |
总流入:--万元
总流出:--万元
净 额:--万元
据统计,近10日内主力筹码较分散,呈低度控盘状态。
公司简介
- 所属地域:
- 海南省
- 涉及概念:
- 合成生物,NMN概念,CRO概念...
- 主营业务:
- 经营分析
- 兴办工厂,西药原料药、中间体和制剂、中成药、...
- 上市日期:
- 2017-03-28
- 每股净资产:
- 6.93元
- 每股收益:
- 0.93元
- 净利润:
- 4.04亿元
- 净利润增长率:
- -11.23%
- 营业收入:
- 13.52亿元
- 每股现金流:
- 0.07元
- 每股公积金:
- 1.50元
- 每股未分配利润:
- 4.20元
- 总股本:
- 4.52亿
- 流通股:
- 3.38亿
单位:万元
{"year":[2023,2022],"s03":[13843.31,""],"s06":[26994.56,28761.14],"s09":[40430.03,45546.41],"s12":["",42061.57]}
同行业市场表现排行
3.5
综合判断:3.5分
打败了1%的股票!
长期趋势:
已有88家主力机构披露2023-12-31报告期持股数据,持仓量总计1725.83万股,占流通A股5.10%
近期的平均成本为12.35元。该股资金方面呈流出状态,投资者请谨慎投资。该公司运营状况尚可,暂时未获得多数机构的显著认同,后续可继续关注。 [诊断日期:2024年05月21日 17:09]
技术面诊股1.80
资金面诊股4.20
消息面诊股3.30
行业面诊股1.60
基本面诊股5.90
最近60个交易日,机构对该股票关注较少,无任何评级。
该股2023年每股收益与前一年相同,长期投资价值一般。
[{"date":"2019","yellowRectValue":"3.01","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"4.07","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"4.17","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.21","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.61","blueLineValue":"1.03","type":"YC"}]
融资融券
查看历史融资融券信息>>
融资余额若长期增加时表示投资者心态偏向买方,市场人气旺盛属强势市场;反之则属弱势市场。
交易日期 |
融资余额(亿元) |
融资余额/流通市值 |
融资买入额(亿元) |
融券卖出量(万股) |
融券余量(万股) |
融券余额(万元) |
融资融券余额(亿元) |
2024-05-20 |
3.69
|
8.84%
|
0.000
|
0.00 |
31.01 |
383.03 |
3.73
|
2024-05-17 |
3.72
|
8.90%
|
0.000
|
0.00 |
31.01 |
383.03 |
3.76
|
2024-05-16 |
3.74
|
8.96%
|
0.000
|
0.00 |
31.01 |
383.03 |
3.78
|
2024-05-15 |
3.78
|
9.04%
|
0.000
|
0.00 |
31.01 |
383.03 |
3.82
|
2024-05-14 |
3.80
|
9.10%
|
0.000
|
0.00 |
31.01 |
383.03 |
3.84
|
2024-05-13 |
3.82
|
9.14%
|
0.000
|
0.00 |
31.01 |
383.03 |
3.86
|
2024-05-10 |
3.85
|
9.22%
|
0.000
|
0.00 |
31.18 |
385.12 |
3.89
|
2024-05-09 |
3.88
|
9.30%
|
0.000
|
0.00 |
31.63 |
390.68 |
3.92
|
2024-05-08 |
3.94
|
9.43%
|
0.000
|
0.00 |
31.63 |
390.68 |
3.98
|
2024-05-07 |
3.97
|
9.50%
|
0.000
|
0.00 |
31.63 |
390.68 |
4.01
|
|
百利天恒 |
普利制药 |
华特达因 |
艾力斯 |
摊薄每股收益 |
12.48 |
0.93 |
0.72 |
0.68 |
行业排名 |
1 |
2 |
3 |
4 |
[["2023-09-30","40430.03","0.93"],["2023-06-30","26994.56","0.62"],["2023-03-31","13843.31","0.32"],["2022-12-31","42061.57","0.96"],["2022-09-30","45546.41","1.04"]]
[["\u767e\u5229\u5929\u6052","12.48"],["\u666e\u5229\u5236\u836f","0.93"],["\u534e\u7279\u8fbe\u56e0","0.72"],["\u827e\u529b\u65af","0.68"]]|1
300630
深证成指
399001
sz
1140
普利制药
[{"date":"20240419","item0":"-1.76","item1":"2.26"},{"date":"20240422","item0":"-0.32","item1":"-0.48"},{"date":"20240423","item0":"0.15","item1":"0.48"},{"date":"20240424","item0":"0.70","item1":"0.14"},{"date":"20240425","item0":"-0.04","item1":"0.00"},{"date":"20240426","item0":"3.34","item1":"0.96"},{"date":"20240429","item0":"3.50","item1":"3.61"},{"date":"20240430","item0":"-1.55","item1":"-18.75"},{"date":"20240506","item0":"1.98","item1":"0"},{"date":"20240507","item0":"-0.14","item1":"0"},{"date":"20240508","item0":"-1.45","item1":"0"},{"date":"20240509","item0":"1.87","item1":"0"},{"date":"20240510","item0":"-1.15","item1":"0"},{"date":"20240513","item0":"-0.95","item1":"0"},{"date":"20240514","item0":"-0.26","item1":"0"},{"date":"20240515","item0":"-0.90","item1":"0"},{"date":"20240516","item0":"0.29","item1":"0"},{"date":"20240517","item0":"1.12","item1":"0"},{"date":"20240520","item0":"0.59","item1":"0"},{"date":"20240521","item0":"-0.77","item1":"0"}]
||
您尚未登录,请登录后再添加自选股!